InvestorsHub Logo
icon url

WeeZuhl

03/04/21 12:26 PM

#352553 RE: WeeZuhl #352544

Combining the extended release formula and the PEG-based hard shell to form a safe and effective ADF is no slam dunk, especially for a company that failed in 2 tries to get FDA approval for a simple oxyIR bead.






Maybe we could get a quick and easy NDA approval for an abuse-deterrent version of the immediate-release drug, as a proof of concept. Hmmm. Where have I heard this before?